Thursday, April 12, 2018

7:00 - 8:40 AM

Networking Breakfast

Sponsored By:

Aerie Pharmaceuticals

7:00 - 7:45 AM

Breakout Attendee Check-in

7:45 - 8:30 AM

Breakout Sessions

Dry Eye: Recent Approvals and Integration into Practice - OD and MD Perspectives

Participants:
Joseph Boorady, OD, Global VP, Ocular Surface Disease - Johnson & Johnson Vision
Susan Benton, Global New Products Lead & Global Product Strategy, Ophthalmics - Shire
Jai G. Parekh, MD, MBA, VP, Global Medical Affairs Office of CMO, Eyecare & Dermatology - Allergan

Co-Moderator By:
Eric Donnenfeld, MD, Clinical Professor of Ophthalmology - NYU/ Ophthalmic Consultants of Long Island
Paul Karpecki, OD, Associate Professor - UPike College of Optometry/Kentucky Eye Institute

Emerging Glaucoma Therapies

Participants:
Matt Larson, President & COO - Equinox

Richard Lewis, MD
, Chief Medical Officer - Aerie Pharmaceuticals
Nick Tarantino, ODSVP, Clinical Research and Medical Affairs - Glaukos Corporation

Co-Moderated By:
Thomas W. Samuelson, MD - Minnesota Eye Consultants
Yang Sun, MD, PhD, Associate Professor - Stanford University

Presbyopia Correction: Non-Surgical Options Today and on the Horizon

Terry Kim, MD, Professor of Ophthalmology - Duke University Eye Center/Lead Researcher - Presbyopia Therapies
Jag Dosanjh, Senior Vice President, Eye Care - Allergan
Sheri Rowen, MD - NVISION Eye Center

Co-Moderated By:
Richard L. Lindstrom, MD, Founder & Attending Surgeon - Minnesota Eye Consultants
Elizabeth Yeu, MD - Virginia Eye Consultants

Ocular Gene Therapy - Beyond Retina

Participants:
Thomas Chalberg, PhD, Managing Director - Heroic Ventures
Wiley Chambers, MD, Deputy Director, Division of Transplant & Ophthalmology Products Center for Drug Evaluation & Research – FDA
Paul Sieving, MD, PhD, Director of the National Eye Institute - NIH

Co-Moderated By:
Thomas Ciulla, MD, VP, Ophthalmology Strategy Lead - Spark Therapeutics/Volunteer Clinical Professor of Ophthalmology - Indiana University School of Medicine
Barrett Katz, MDChief Medical Officer - GenSight Biologics

Cataract Surgery - Five Year Outlook

Participants:
David Chang, MD - Altos Eye Physicians
Vance Thompson, MD - Vance Thompson Vision
Kendall Donaldson, MD, Associate Professor of Ophthalmology - Bascom Palmer Eye Institute
William Wiley, MD, Medical Director - Cleveland Eye Clinic

Moderated By:
Kerry Solomon, MD, Cataract & Refractive Surgery - Carolina Eyecare Physicians

8:00 - 8:40 AM

General Attendee Check-in

8:40 - 8:50 AM

Summit Kick off with Ophthalmology Innovation Cycle & Financing Update

Presented By:
William J. Link, PhD, Managing Director - Versant Ventures

8:50 - 10:10 AM

Ophthalmology Innovation Showcase

Introduced By:
Brent Jones, National Sales Director, Ophthalmics - Sun Pharmaceutical Industries
William Wiley, MD, Medical Director - Cleveland Eye Clinic

8:50 - 8:56 | AcuFocus | Yari Mitchell, VP, Medical Affairs & Business Strategy
8:56 - 9:02 | PowerVision | Barry Cheskin, Co-Founder, President & CEO
9:02 - 9:08 | Cassini | Mark Packer, MD, Chief Medical Officer
9:08 - 9:14 | Allotex | David Muller, CEO
9:14 - 9:20 | KERANOVA | Fabrice Romano, CEO & Chairman
9:20 - 9:26 | Perfect Lens | Steven Smathers, President
9:26 - 9:32 | iVeena Delivery Systems | Bala Ambati, MD, PhD, MBA, President & Founder
9:32 - 9:38 | LacriScience | Vladimir Feingold, CEO
9: 38 - 9:44 | BlephEx | James Rynerson, MD, President & CEO
9:44 - 9:50 | Refocus Group | Mike Judy, CEO
9:50 - 9:56 | CorneaGen | Monty Montoya, President & CEO
9:56 - 10:02 | Kedalion Therapeutics | Peter Noymer, PhD, CEO
10:02 - 10:08 | Panoptes Pharma | Franz Obermayr, PhD, CEO

10:10 - 10:40 AM

Morning Networking & Refreshment Break

Sponsored By:

santen

10:40 - 11:25 AM

Spotlight on Dry Eye

Recent developments on dry eye disease treatment.

  1. Market Overview
    Presented By:
    Edward Holland, MD, Director, Cornea Services - Cincinnati Eye Institute
  2. Company Presentations
    10:45 - 10:51 | Kala Pharmaceuticals | Mark Iwicki, Chairman & CEO
    10:51 - 10:57 | Oyster Point Pharma | Jeffrey Nau, PhD, President & CEO
    10:57 - 11:03 | Sight Sciences | Shawn O’Neil, SVP, Sales & Marketing
    11:03 - 11:09 | Tear Film Innovations | Rob Thornhill, CEO
  3. Panel Discussion
    Participants:
    John Sheppard, MD, President - Virginia Eye Consultants
    Preeya Gupta, MD, Associate Professor of Ophthalmology, Cornea & Refractive Surgery - Duke University Eye Center
    Sam Garg, MD, Vice Chair of Clinical Ophthalmology & Medical Director - Gavin Herbert Eye Institute, UC Irvine

11:25 - 12:10 PM

Spotlight on MIGS

Competitive activity and progress in MIGS.

  1. Market Overview
    Presented By:
    Kuldev Singh, MD, MPH - Stanford University
  2. Panel Discussion
    Participants:
  3. Jag Dosanjh, Senior Vice President, Eye Care - Allergan
    Joseph Gilliam, CFO & SVP, Corporate Development - Glaukos
    Michael Onuscheck, President & General Manager, Global Surgical Franchise - Alcon
    Ram Palanki, PharmD, SVP of Commercial, Americas - Santen
    Jane Rady, SVP, Corporate Strategy & Business Development - Glaukos Corporation
    Jonathan Talamo, MD, Chief Medical Officer, VP Medical & Clinical Affairs - Johnson & Johnson Vision

    Co-Moderated By:
    Thomas W. Samuelson, MD - Minnesota Eye Consultants
    Kuldev Singh, MD - Stanford University

12:10 - 12:45 PM

Networking Lunch

Sponsored By:

Johnson & Johnson Vision

12:45 - 1:05 PM

Special Recognition

Presented To:
David Karcher, Executive Director - American Society of Cataract & Refractive Surgery

1:05 - 1:15 PM

FDA Fireside Chat

Participants:
Malvina Eydelman, MD, Director, Division of Ophthalmic and Ear, Nose & Throat Devices - FDA
William J. Link, PhD, Managing Director - Versant Ventures

1:15 - 1:55 PM

Optimizing Reimbursement

Opportunities and challenges for providers and companies.

Participants:
Greg Kunst, Sr. Director, Global Market Access & Business Development - Glaukos Corporation
Raj Rajpal, MD, Chief Medical Officer - Avedro
Allison Shuren, Partner - Arnold & Porter
Kuo Tong, Managing Director - Navigant Consulting

Moderated By:
John Berdahl, MD - Vance Thompson Vision

1:55 - 2:35 PM

The Femto Frontier: Exploring New Applications

The history of femtosecond lasers and what’s on the horizon.

  1. Introduction and Market Overview
    Presented By:
    Gilbert H. Kliman, MD, Managing Director - InterWest Partners
  2. History and Future of Femto
    Presented By:
    Tibor Juhasz, PhD - UC, Irvine
  3. Panel Discussion
    Participants:
    Steve Slade, MD - Slade & Baker Vision/Femtosecond Clinical Pioneer
    Dirk Muehlhoff, VP, Refractive Laser Business Unit - Carl Zeiss Meditec AG
    Nicholas Curtis, President & CEO - LENSAR
    Mark Packer, MD - Mark Packer Consulting/KERANOVA Investigator
    George Waring IV, MD - Waring Vision Institute/Perfect Lens Investigator

    Moderated By:
    Gilbert H. Kliman, MD, Managing Director - InterWest Partners
2:35 - 3:05 PM

Afternoon Networking & Refreshment Break

Sponsored By:

santen

3:05 - 3:50 PM

Public Spotlight

Public market activity and company developments.

  1. Financial Overview
    Presented By:
    Andrew Gitkin, Head of West Coast Biotech Investment Banking - Piper Jaffray
  2. OIS Index Quarterly Update
    Presented By:
    Michael Lachman, President - EyeQ Research
  3. Company Presentations
    3:18 - 3:26 | Aerie Pharmaceuticals | Tom Mitro, COO & President
    3:26 - 3:34 | Ellex | Tom Spurling, CEO
    3:34 - 3:42 | Nicox S.A. | Michele Garufi, PharmD, Co-Founder, Chairman & CEO
    3:42 - 3:50 | EyePoint Pharmaceuticals | Nancy Lurker, President & CEO
3:50 - 4:40 PM

Masters of the Industry

Industry Executives share how they manage innovation, integration and other challenges facing big companies today.

Participants:
Robert Dempsey, Group Vice President - Head of Global Ophthalmics Franchise - Shire
David Endicott, Chief Operating Officer - Alcon
Tom Frinzi, Worldwide President, Surgical - Johnson & Johnson Vision
William J. Link, PhD, Managing Director - Versant Ventures
William Meury, Chief Commercial Officer - Allergan
Ludwin Monz, PhD, President & CEO - Carl Zeiss Meditec AG
Tracy Valorie, SVP, General Manager US Pharmaceuticals & Surgical Business - Bausch + Lomb

Moderated By:
Jim Mazzo, Global President Ophthalmic Devices - Carl Zeiss Meditec

4:40 - 4:50 PM

Closing Remarks

Gilbert H. Kliman, MD, Managing Director - InterWest Partners

4:50 - 5:50 PM

Networking Reception

Sponsored By:
Alcon